Mucormycosis is an emerging disease primarily affecting the immunocompromised host, but scarce evidence is available for solid organ transplant recipients (SOTRs). We systematically reviewed 183 cases occurring in SOTRs, exploring epidemiology, clinical characteristics, causative pathogens, therapeutic approaches, and outcomes. Kidney transplants accounted for half of the cases, followed by heart (18.6%), liver (16.9%), and lung (10.4%). Diagnosis showed a dichotomous distribution, with 63.7% of cases reported within 100 days of transplantation and 20.6% occurring at least 1 year after transplant. The 90-day and 1-year mortality rates were 36.3% and 63.4%, respectively. Disseminated disease had the highest mortality at both time points (75% and 93%). Treatment with >3 immunosuppressive drugs showed a significant impact on 90-day mortality (odds ratio [OR], 2.33; 95% CI, 1.02-5.66; P =. 0493), as did a disseminated disease manifestation (OR, 8.23; 95% CI, 2.20-36.71; P =. 0027) and the presence of diabetes (OR, 2.35; 95% CI, 1.01-5.65; P =. 0497). Notably, prophylaxis was administered to 12 cases with amphotericin B. Further investigations are needed to validate these findings and to evaluate the potential implementation of prophylactic regimens in SOTRs at high risk.
CITATION STYLE
Palomba, E., Colaneri, M., Azzarà, C., Fava, M., MacCaro, A., Renisi, G., … Bandera, A. (2024, June 1). Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases. Open Forum Infectious Diseases. Oxford University Press. https://doi.org/10.1093/ofid/ofae043
Mendeley helps you to discover research relevant for your work.